Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Sarcoma

• A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Bone and Soft Tissue Tumors
• Cabozantinib With Ifosfamide in Ewing's Sarcoma and Osteosarcoma
• Pembrolizumab in Combination With Eftilagimod Alpha and Radiotherapy in Neoadjuvant Treatment of Patients With Soft Tissue Sarcoma - EFTISARC-NEO Trial
• Clinical Study of VG161 in the Treatment of Advanced Bone and Soft Tissue Sarcoma
• Safety and Efficacy of NK510 to Treat Osteosarcoma and Soft Tissue Sarcoma
• Efficacy and Safety Study of Cardunilizumab in Soft Tissue Sarcoma
• Selinexor Plus Gemcitabine in Selected Advanced Soft-tissue Sarcoma (SeliSarc)
• Palbociclib and Pembrolizumab in Undifferentiated Pleomorphic Sarcoma (UPS)
• A Study of Surufatinib in the Treatment of Advanced Soft Tissue Sarcoma
• Targeting MDMD and PD1 in Tumors With Tertiary Lymphoid Structures
• Phase I/Ib Study of NK Expressing an Affinity-enhanced T-cell Receptor (TCR) Against the NY-ESO-1
• A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing
• Phase II Study of Pacritinib in Kaposi Sarcoma Herpesvirus (KSHV)-Associated Multicentric Castleman Disease and KSHV-Associated Inflammatory Cytokine Syndrome (KICS)
• Lurbinectedin in FET-Fused Tumors
• Brachytherapy (Iodine-125 Seeds) and Fluzoparib Combination Therapy for Advanced Unresectable Soft Tissue Sarcoma
• A Study of Etrumadenant and Zimberelimab in People With Dedifferentiated Liposarcoma
• LINNOVATEL: Lurbinectedin, Ipilimumab and Nivolumab for Soft Tissue Sarcoma
• A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer
• Study of DPPG2-TSL-DOX Combined With Hyperthermia in Soft Tissue Sarcoma
• A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Bone and Soft Tissue Tumors
• A Phase II Single-arm Study of Pembrolizumab Plus Lenvatinib in Previously Treated Classic Kaposi Sarcoma
• Neoadjuvant Chemotherapy Combined With Targeted Treatment in High-risk Retroperitoneal Sarcoma
• The Combination of Radiotherapy，Surufatinib and Sintilimab in High-Risk Localized Soft Tissue Sarcoma
• Testing Ipilimumab and Nivolumab Combination With or Without Cabozantinib in People >= 18 Years Old With Advanced Soft Tissue Sarcoma
• HS-20093 in Patients With Relapsed or Refractory Osteosarcoma and Other Sarcomas
• Neoadjuvant ADI-PEG 20 + Ifosfamide + Radiotherapy in Soft Tissue Sarcoma
• Randomized Phase I/II Trial of LB-100 Plus Doxorubicin vs Doxorubicin Alone of Advanced Soft Tissue Sarcomas
• A Study of Propranolol to Treat Kaposi Sarcoma
• The Combination of Radiotherapy, Chemotherapy and Immunotherapy in High-Risk Localized Soft Tissue Sarcoma
• A Clinical Study to Investigate the Efficacy of Intratumoral Tigilanol Tiglate in Soft Tissue Sarcoma
• Anrotinib Hydrochloride Combined With Adriamycin for Neoadjuvant Treatment of High-grade Soft Tissue Sarcoma
• Culturally Adapted Mobile Treatment of Chronic Pain in Adolescent Survivors of Pediatric Bone Sarcoma
• Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma
• Immunotherapy for Recurrent Osteogenic Sarcoma
• Surufatinib and Envafolimab as Second or More-line Therapy in Advanced Soft Tissue Sarcoma Patients
• Piamprilizumab (AK105) Combined With Radiotherapy for Neoadjuvant Treatment of Soft Tissue Sarcoma
• Study of ADI-PEG 20 or Placebo Plus Gem and Doc in Previously Treated Subjects With Leiomyosarcoma (ARGSARC)
• Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma
• Testing the Addition of Cemiplimab to Palbociclib for the Treatment of Advanced Dedifferentiated Liposarcoma
• Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With CRC, NSCLC, and STS
• Pazopanib With or Without Pembrolizumab for Metastatic Soft Tissue Sarcoma
• Irinotecan and Anlotinib for Epithelioid Sarcoma
• TAS-116 Plus Palbociclib in Breast and Rb-null Cancer
• Preliminary Assessment of Safety and Tolerability of Dostarlimab in Combination Antiretroviral Therapy (cART) Refractory HIV Associated Kaposi Sarcoma
• A First-In-Human Phase 1 Trial of T-Cell Membrane-Anchored Tumor Targeted Il12 (Attil12)- T-Cell Therapy in Subjects With Advanced/Metastatic Soft Tissue and Bone Sarcoma
• Lenvatinib for Advanced Bone and Soft Tissue Sarcoma
• A Phase 1 Study of [225Ac]-FPI-2059 in Adult Participants With NTSR1-Expressing Advanced, Metastatic and/or Recurrent Solid Tumours
• Anlotinib and Radiotherapy in Resectable Soft Tissue Sarcoma
• tTF-NGR Randomized Study - STS
• 89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors
• Phase II Study of Chiauranib Capsule in Advanced or Unresectable Soft Tissue Sarcoma
• A Phase 1 Study of PRT3645 in Participants With Select Advanced or Metastatic Solid Tumors
• Phase 1b/2 Study of Liposomal Annamycin (L-Annamycin) in Subjects With Previously Treated Soft-Tissue Sarcomas (STS) With Pulmonary Metastases
• A Study of Niraparib in People With Soft Tissue Sarcoma Who Have Changes in Their Tumor DNA
• Chiauranib for Advanced or Unresectable Soft Tissue Sarcoma(STS)
• Pembrolizumab Combined With Radiotherapy for Metastatic Sarcoma
• YH001 Plus Envafolimab With or Without Doxorubicin in Patients With Advanced or Metastatic Sarcoma
• CAMPFIRE: A Study of Abemaciclib (LY2835219) in Participants With Ewing's Sarcoma
• FAPi Radioligand OpeN-Label, Phase 1 Study to Evaluate Safety, Tolerability and DosImetry of [Lu-177]-PNT6555; A Dose Escalation Study for TReatment of Patients With Select Solid Tumors (FRONTIER)
• Efficacy of Tranexamic Acid in Preventing Post Operative Blood Loss in Bone Sarcoma Patient
• Theranostics in Soft Tissue Sarcoma Using a Vascular Disruption Approach
• Study of Safety, Pharmacokinetic and Efficacy of APG-5918 in Advanced Solid Tumors or Lymphomas
• Paclitaxel and Pegylated Liposomal Doxorubicin for Treatment of HIV-related Kaposi Sarcoma
• Tazemetostat+Nivo/Ipi in INI1-Neg/SMARCA4-Def Tumors
• Regorafenib in Patients With Refractory Primary Bone Tumors
• A Study to Assess the Safety and Tolerability of CFT8634 in Locally Advanced or Metastatic SMARCB1-Perturbed Cancers, Including Synovial Sarcoma and SMARCB1-Null Tumors
• Testing Atezolizumab With or Without Selinexor in Patients >= 18 Years Old With Alveolar Soft Part Sarcoma
• A Randomised Placebo-Controlled Study of Use of GnRHa During Chemotherapy for Fertility Protection of Young Women With Cancer
• A Phase I Feasibility And Safety Study of Fluorescein-Specific (FITC-Ew) CAR T Cells In Combination With Parenterally Administered Folate-Fluorescein (UB-TT170) For Osteogenic Sarcoma
• Anti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic Cancers
• A Study of LY2880070 and Gemcitabine in People With Ewing Sarcoma or Ewing-Like Sarcoma
• A Rollover Protocol to Allow for Continued Access to the LSD1 Inhibitor Seclidemstat (SP-2577)
• Clinical Trial of TQB2858 Injection in the Treatment of Advanced High-grade Sarcoma
• Trial of Selumetinib and AZD5153 With Durvalumab for Sarcomas
• Preoperative IMRT With Concurrent Apatinib for Localised Extremity or Trunk Sarcoma
• A Study of HFB301001 in Adult Patients With Advanced Solid Tumors
• Disulfiram With Copper Gluconate and Liposomal Doxorubicin in Treatment-Refractory Sarcomas
• Sotorasib and Panitumumab Versus Investigator's Choice for Participants With Kirsten Rat Sarcoma (KRAS) p.G12C Mutation
• A Phase II Study for 609A in the Treatment of Advanced Undifferentiated Pleomorphic Sarcoma
• Albumin-bound Paclitaxel Plus Camrelizumab for Advanced Soft Tissue Sarcoma.
• Combination of Pembrolizumab and Cabozantinib in Patients With Advanced Sarcomas
• HDM201 and Pazopanib in Patients With P53 Wild-type Advanced/Metastatic Soft Tissue Sarcomas
• Niraparib for the Treatment of Leiomyosarcoma
• Preoperative IMRT With Concurrent Anlotinib for Localised Extremity or Trunk Sarcoma
• A Study of PRT2527 in Patients With Advanced Solid Tumors
• Study on Tolerability and Pharmacokinetics of TQB2858 Injection in Subjects With Advanced Malignant Tumors
• Multicohort Trial of Different Schemes of PM14 in Monotherapy and in Combination With Radiotherapy in Soft Tissue Sarcomas and Other Solid Tumor
• Fruquintinib in the Treatment of Soft Tissue Sarcoma
• A Phase 2 Clinical Study of Evaluation of Recombinant Anti-PD-1 Humanized Monoclonal Antibody Injection (609A) Combined With Doxorubicin Hydrochloride in the Treatment of Metastatic/Unresectable Non-specific Soft Tissue Sarcoma
• A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
• Multicohort Trial of Trabectedin and Low-dose Radiation Therapy in Advanced/Metastatic Sarcomas
• GD2-SADA:177Lu-DOTA Complex in Patients With Solid Tumors Known to Express GD2
• A Clinical Trial to Evaluate the Efficacy and Safety of Anotinib Hydrochloride Capsule Combined With Epirubicin Hydrochloride Versus Placebo Combined With Epirubicin Hydrochloride in First-line Treatment of Advanced Soft Tissue Sarcoma
• Phase 2 Study of 9-ING-41 With Chemotherapy in Sarcoma
• Surufatinib in Patients With Osteosarcoma and Soft Tissue Sarcoma
• A Study of NOX66 Plus Doxorubicin in Anthracycline-naïve, Adult Patients With Soft Tissue Sarcoma
• Lurbinectedin + Doxorubicin In Leiomyosarcoma
• A Study of Surufatinib in Combination With Gemcitabine in Pediatric, Adolescent, and Young Adult Patients With Recurrent or Refractory Solid Tumors
• Study of LVGN3616 and LVGN6501±LVGN7409 in Combination With Nab-Paclitaxel or Bevacizumab and Cyclophosphamide in Metastatic Solid Tumors
• Elimusertib for the Treatment of Relapsed or Refractory Solid Tumors
• Neoadjuvant Combination of Doxorubicin, Cisplatin and Methotrexate in Patients Aged 24-40 Years With Primary Bone Tumors
• Camsirubicin + Pegfilgrastim to Determine MTD in ASTS
• Lurbinectedin With or Without Irinotecan in Treating Patients With Relapsed or High Risk Metastatic Ewing Sarcoma
• Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types
• HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma
• A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours
• Neoadjuvant Chemotherapy and Retifanlimab in Patients With Selected Retroperitoneal Sarcomas (TORNADO)
• FHD-609 in Subjects With Advanced Synovial Sarcoma
• Abemaciclib in Patients With HIV-associated and HIV-negative Kaposi Sarcoma
• Camrelizumab Plus Doxorubicin for the First Line Treatment of Adcanced Soft Tissue Sarcoma
• A Phase 2 Study of 9-ING-41Combined With Chemotherapy in Adolescents and Adults With Advanced Sarcomas
• Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
• A Study of Mitoxantrone Hydrochloride Liposome Injection in Subjects With Advanced Bone and Soft Tissue Sarcoma
• B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)
• Vincristine and Temozolomide in Combination With PEN-866 for Adolescents and Young Adults With Relapsed or Refractory Solid Tumors
• Study of Liposomal Annamycin for the Treatment of Subjects With Soft-Tissue Sarcomas (STS) With Pulmonary Metastases
• Gemcitabine With Ascorbate Including Adolescents
• Bintrafusp Alfa and Doxorubicin Hydrochloride in Treating Patients With Advanced Sarcoma
• Indo-cyanine Green (ICG) in Paediatric Oncology MIS
• Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
• A Study of PRT1419 in Patients With Advanced Solid Tumors
• A Study of Different Dosing Schedules of Selinexor in Sarcoma Patients
• Targeting ATR in Soft-tissue Sarcomas
• Study of Adoptive Immunotherapy in Relapsed and Non-resectable Sarcomas After Multimodal Treatment.
• A Pilot Study of Thermodox and MR-HIFU for Treatment of Relapsed Solid Tumors
• Lenvatinib and Pembrolizumab in People With Advanced Soft Tissue Sarcoma
• A 3 Arm Randomized Study on Health-related QoL of Elderly Patients With Advanced Soft Tissue Sarcoma
• Sequential Neoadjuvant Chemotherapy in Soft Tissue Sarcoma
• Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumors
• A Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of ION363 in Amyotrophic Lateral Sclerosis Participants With Fused in Sarcoma Mutations (FUS-ALS)
• Pegylated Liposomal Doxorubicin Combined With Anlotinib for Neoadjuvant Treatment of Soft Tissue Sarcoma
• Metformin as Maintenance Therapy in Patients With Bone Sarcoma and High Risk of Relapse
• Comparison of Oral Cyclophosphamide vs Doxorubicin in ≥65 Years Old Advanced or Metastatic Soft Tissue Sarcoma Patients
• Efficacy of the Combination of Nivolumab and Ipilimumab as a Treatment in Patients With Sarcoma of Rare Subtype
• Efficacy and Safety of L19TNF in Previously Treated Patients With Advanced Stage or Metastatic Soft-tissue Sarcoma
• A Clinical Trial Assessing BT-001 Alone and in Combination With Pembrolizumab in Metastatic or Advanced Solid Tumors
• Fluorescent Intra-operative Tumor Margin Examination
• Combining Epigenetic And Immune Therapy to Beat Cancer.
• Efficacy of Regorafenib Combined With Best Supportive Care as Maintenance Treatment in High Grade Bone Sarcomas Patients
• TQB3525 for Advanced Bone Sarcomas With PI3KA Mutations or PTEN Loss
• Cabozantinib With Topotecan-Cyclophosphamide
• Phase I Clinical Trial of Anlotinib in Progressive, Recurrent, and Refractory Sarcoma in Children
• Low Dose Continuous Cyclophosphamide vs Standard Doxorubicin in Advanced Sarcoma Elderly Patients
• A Study Comparing the Efficacy of L19TNF+Doxorubicin vs Doxorubicin Alone as First-line Therapy in Patients With Advanced or Metastatic Soft Tissue Sarcoma
• Aerosolized Azacytidine as Epigenetic Priming for Bintrafusp Alfa-Mediated Immune Checkpoint Blockade in Patients With Unresectable Pulmonary Metastases From Sarcomas, Germ Cell Tumors, or Epithelial Malignancies
• A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors
• Gemcitabine Plus Ascorbate for Sarcoma in Adults (Pilot)
• Study of Camrelizumab in Combination With Neoadjuvant Chemotherapy in the Treatment of High-risk Soft Tissue Sarcoma
• Pemetrexed, Cisplatin With Soft Tissue Sarcoma
• TVEC and Preop Radiation for Sarcoma (8 ml Dose)
• Selinexor Plus Gemcitabine in Selected Advanced Soft-tissue Sarcoma and Osteosarcoma
• Testing the Anti-cancer Drug, Rogaratinib (BAY 1163877), for Treatment of Advanced Sarcoma With Alteration in Fibroblast Growth Factor Receptor (FGFR 1-4), and in Patients With SDH-deficient Gastrointestinal Stromal Tumor (GIST)
• To Evaluate Maximally Tolerated Dose (MTD), Safety and Efficacy of CPI-613® (Devimistat) Plus Hydroxychloroquine in Patients With Relapsed or Refractory Clear Cell Sarcoma of Soft Tissue
• Adriamycin and Ifosfamide Combined With Sintilimab
• Toripalimab Combined With CAV / IE Regimen
• Surufatinib in Combination With Tislelizumab in Subjects With Advanced Solid Tumors
• Pomalidomide Treatment in Patients With Kaposi Sarcoma
• Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma
• Cabozantinib Combined With PD-1 and CTLA-4 Inhibition in Metastatic Soft Tissue Sarcoma
• A Two-part Study to Characterize Drug-Drug Interaction Effects on Steady-State Pharmacokinetics of Oral Tazemetostat
• GALLANT: Metronomic Gemcitabine, Doxorubicin, Docetaxel and Nivolumab for Advanced Sarcoma
• Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV
• ENVASARC: Envafolimab And Envafolimab With Ipilimumab In Patients With Undifferentiated Pleomorphic Sarcoma Or Myxofibrosarcoma
• Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR Cancers
• Testing Atezolizumab in Patients >= 2 Years Old With Newly Diagnosed, Unresectable, or Metastatic Clear Cell Sarcoma or Chondrosarcoma
• 68Ga-FAPi-46 PET/CT Scan in Imaging Patients With Sarcoma
• A Study of Carilizumab in Combination With Apatinib in Subjects With Unresectable UPS and ASPS
• Nivolumab and BO-112 Before Surgery for the Treatment of Resectable Soft Tissue Sarcoma
• Study of Nivolumab and Ipilimumab in Children and Young Adults With INI1-Negative Cancers
• Trial in Patients With Metastatic or Locally Advanced Leiomyosarcoma
• The Combination of Sintilimab and AI (Doxorubicin, ADM/Ifosfamide, IFO) for the First Line Treatment of Select Type of Metastatic/Unresectable Soft Tissue Sarcoma
• Tranexamic Acid in Radical Resection and Endoprosthetic Reconstruction
• Flavored, Oral Irinotecan VAL-413 (Orotecan®) Given With Temozolomide for Treatment of Recurrent Pediatric Solid Tumors
• A Study of Pembrolizumab Plus Local Chemotherapy Using Isolated Limb Infusion (ILI) for Patients With Sarcoma in the Arm or Leg
• Selpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic Disorders With Activating RET Gene Alterations, a Pediatric MATCH Treatment Trial
• Interest of Peri Operative CHemotherapy In Patients With CINSARC High-risk Localized Grade 1 or 2 Soft Tissue Sarcoma
• Trial of Ixazomib for Kaposi Sarcoma
• NHS-IL12 Monotherapy and in Combination With M7824 in Advanced Kaposi Sarcoma
• Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment Trial
• Study on TSR-042 in Advanced Clear Cell Sarcoma
• Study of DCC-3014 in Combination With Avelumab in Patients With Advanced or Metastatic Sarcomas
• Clinical Study of PD-1 Monoclonal Antibody SHR-1210 and Apatinib in Advanced NSCLC, Soft Tissue Sarcoma, and Uterine Cancer
• Study on the Treatment of Soft Tissue Sarcoma With First-line Chemotherapy Failure by Anrotenil Hydrochloride Capsule
• Cabozantinib With Radiation Therapy for the Treatment of Sarcomas of the Extremities
• MEK Inhibitor and a PDL1 Inhibitor Patients With Locally Advanced and/or Metastatic Soft Tissue Sarcoma
• Heated Intra-peritoneal Chemotherapy With Doxorubicin and Cisplatin for the Treatment of Resectable, Refractory, or Recurrent Rhabdomyosarcoma in Pediatric Patients, T.O.A.S.T. I.T. Study
• Tazemetostat in Combination With Doxorubicin as Frontline Therapy for Advanced Epithelioid Sarcoma
• Cabozantinib and Temozolomide for the Treatment of Unresectable or Metastatic Leiomyosarcoma or Other Soft Tissue Sarcoma
• Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent Sarcoma
• Ivosidenib in Treating Patients With Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With IDH1 Mutations (A Pediatric MATCH Treatment Trial)
• Repeat or Single Quadratus Lumborum Block for the Reduction of Opioid Prescriptions After Surgery in Retroperitoneal Sarcoma Patients ("RESQU-SARC" Trial)
• Sotorasib Activity in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101)
• BIO-11006 for Osteosarcoma and Ewing's Sarcoma Lung Metastases
• Phase I Study of Radiolabeled OTSA101-DTPA in Patients With Relapsed or Refractory Synovial Sarcoma
• Anlotinib Combined With Toripalimab in Refractory and Advanced Soft-tissue Sarcoma
• A Phase II Study on Adjuvant Vaccination With Dendritic Cells Loaded With Autologous Tumor Homogenate in Resected Stage IV Rare Cancers.
• Evaluation of AL3818 in Combination With Nivolumab in Solid Tumors
• CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Synovial Sarcoma
• Selinexor as a Single Agent and in Combination With Imatinib in Patients With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors.
• Palbociclib + Ganitumab In Ewing Sarcoma
• Study of SHR-1210 Combined With Apatinib in the Treatment of Sarcoma
• Apatinib Combined With Chemotherapy in the Treatment of Soft Tissue Sarcoma
• Ipilimumab +Nivolumab + Cryotherapy in Metastatic or Locally Advanced Soft Tissue Sarcoma
• Combination of Nivolumab Plus Relatlimab in Patients With Advanced or Metastatic Soft-tissue Sarcoma: a Proof-of-concept Randomized Phase II Study
• Trabectedin in Combination With Olaparib in Advanced Unresectable or Metastatic Sarcoma
• BIOmarker Driven Trial of VEGFR2 Inhibitor in Advanced Sarcoma
• SARC037: A Phase I Study to Evaluate the Safety of Trabectedin in Combination With Irinotecan in Ewing Sarcoma Patients
• Phase II Multicenter Study of Talimogene Laherparepvec in Classic or Endemic Kaposi Sarcoma
• Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas
• Lymphodepletion Plus Adoptive Cell Therapy With High Dose IL-2 in Adolescent and Young Adult Patients With Soft Tissue Sarcoma
• Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway Alteration
• Gemcitabine and Docetaxel With Radiation in Adults With Soft Tissue Sarcoma of the Extremities
• Dose Finding Study of L19TNF and Doxorubicin in Patients With STS
• Surgery With Our Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma
• Doxorubicin Plus Dual Checkpoint Blockade for Soft Tissue Sarcomas
• A Single-arm, Open, Phase II Study of Chidamide Combined With Toripalimab in Refractory and Advanced Soft-tissue Sarcoma
• Apatinib Mesylate Combined With Doxorubicin and Ifosfamide in Advanced Soft-tissue Sarcoma
• Prospective Identification of Predictive Biomarkers of Trabectedin Efficacy in Non-L Soft-tissue Sarcoma Patients
• A Phase 1/2 Study of CYT-0851, an Oral RAD51 Inhibitor, in B-Cell Malignancies and Advanced Solid Tumors
• A Study of sEphB4-HSA in Kaposi Sarcoma
• Olaratumab Plus Trabectedin in Advanced Soft-tissue Sarcoma Patients Soft-tissue Sarcoma Patients
• Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Soft Tissue or Bone Sarcoma Metastatic to the Lungs
• A Safety Study of SGN-CD47M in Patients With Solid Tumors
• Efficacy and Safety of Anlotinib in Adjuvant Therapy for High-grade Soft Tissue Sarcoma
• Study of Anlotinib Hydrochloride and Toripalimab in Subjects With Unresectable or Metastatic Undifferentiated Pleomorphic Sarcoma
• FLuoresence Image Guided Surgery With A VEGF-targeted Tracer in Soft-tissue Sarcomas in Humans Approach With Bevacizumab-IRDye 800CW
• A Phase II Study of Eribulin and Pembrolizumab in Soft Tissue Sarcomas
• A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) Tumors
• Anlotinib Hydrochloride for Soft Tissue Sarcoma Patients.
• Talimogene Laherparepvec, Nivolumab and Trabectedin for Sarcoma
• Anlotinib Hydrochloride Combined With Liposomal Doxorubicin in the Treatment of Locally Advanced or Metastatic Soft Tissue Sarcoma
• Selinexor in Combination With Ixazomib for the Treatment of Advanced Sarcoma
• Liposomal Bupivacaine (Exparel) in Sarcomas
• Rituximab Hyaluronidase in Combination With Chemotherapy in Treating Aggressive B-cell Lymphoma in Uganda
• Randomized Trial in Advanced, Metastatic or Unresectable Soft Tissue Sarcoma After Failure of Standard Treatments.
• Anlotinib Hydrochloride Combined With Epirubicin and Ifosfamide for Soft Tissue Sarcoma Patients
• A Study of Pemetrexed Plus Cisplatin in Patients With Refractory Soft Tissue Sarcoma
• Benefit of Intensified Peri-operative Chemotherapy Within High-risk CINSARC Patients With Resectable Soft-tissue Sarcomas
• A Study of Durvalumab in Combination With Doxorubicin for Advanced Soft Tissue Sarcoma
• A Study of Pazopanib and Durvalumab for Metastatic Soft Tissue Sarcoma
• Phase II Study of Regorafenib as Maintenance Therapy
• Radical Resection and HIPEC for Recurrent Retroperitoneal Sarcoma
• Anlotinib Hydrochloride For Advanced Soft Tissue Sarcoma Patients Who Do Not Receive Chemotherapy
• Molecular Profiling of Advanced Soft-tissue Sarcomas
• SM-88 as Maintenance Therapy for Advanced Ewing's Sarcoma Patients and as Salvage Therapy for Sarcoma Patients
• Study on Leiomyosarcoma, Liposarcomas and Synovial Sarcoma With Trabectedin
• Metabolic Characteristics of Sarcoma In Vivo Using HP 13-C Magnetic Resonance Spectroscopic Imaging (MRSI)
• Acupuncture as the Therapeutic Modalities of Acute Toxicity in the Radiotherapy of Head and Neck Tumors
• Quality of Life in Patients With Non-adipocyte Soft Tissue Sarcoma Under Palliative Chemotherapy or Pazopanib
• FMISO PET/CT Imaging Trial for Assessing Hypoxia in Soft Tissue Sarcomas
• CBL0137 in Treating Patients With Advanced Extremity Melanoma or Sarcoma
• APX005M and Doxorubicin in Advanced Sarcoma
• Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
• A Study of SHR-1210 Plus Apatinib in Patients With Soft Tissue Sarcoma
• Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid Tumors
• Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)
• OlaReDo - Olaratumab and Rechallenge With Doxorubicin in Soft Tissue Sarcoma Patients
• Clinical Trial of Safety, Tolerability and Antitumor Activity of Genetically Engineered T Cells in Combination With Anti-Cancer Agents in Relapsed and Refractory Synovial Sarcoma Expressing New York Esophageal Antigen-1 (NY-ESO-1) and/or LAGE-1a
• Itacitinib in Treating Patients With Refractory Metastatic/Advanced Sarcomas
• Nanoparticle Albumin-Bound Rapamycin and Pazopanib Hydrochloride in Treating Patients With Advanced Nonadipocytic Soft Tissue Sarcomas
• Hypofractionated Radiotherapy With Sequential Chemotherapy in Marginally Resectable Soft Tissue Sarcomas of Extremities or Trunk Wall
• Sunitinib in Sarcomas of the Central Nervous System
• C7R-GD2.CART Cells for Patients With Relapsed or Refractory Neuroblastoma and Other GD2 Positive Cancers (GAIL-N)
• Evaluation of Clinical Impact of Interruption VS Maintenance of AI in Patients With Locally Advanced/ Metastatic Low Grade Endometrial Stromal Sarcoma (LGESS)
• Fluorothymidine F-18 PET in Diagnosing Patients With Intermediate or High Grade Soft Tissue Sarcoma
• Phase 1, First-in-human Study of Oral TP-1287 in Patients With Advanced Solid Tumors
• Phase I Study Compound 451238 and Radiotherapy in Soft-tissue Sarcoma
• Pomalidomide in Treating Patients With Kaposi Sarcoma and Human Immunodeficiency Virus Infection
• Clinical Trial of SP-2577 (Seclidemstat) in Patients With Relapsed or Refractory Ewing or Ewing-related Sarcomas
• Evaluating Quality of Life in Patients With AIDS-Associated Kaposi Sarcoma Treated With Bleomycin and Vincristine
• Combined Treatment With Nivolumab and Trabectedin in Patients With Metastatic or Inoperable Soft Tissue Sarcomas
• Stereotaxic Body Irradiation of Oligometastase in Sarcoma (Stereosarc)
• Radiotherapy Concurrent With Apatinib in Advanced Soft Tissue and Bone Sarcomas of Head and Neck--RASS Study
• Lenvatinib and Eribulin in Advanced Soft Tissue Sarcoma
• Palbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations in Cell Cycle Genes (A Pediatric MATCH Treatment Trial)
• NAPAGE: NAb-PAclitaxel and GEmcitabine in Advanced Soft Tissue Sarcoma
• Safety and Efficacy of IMCnyeso in Advanced NY-ESO-1 and/or LAGE-1A Positive Cancers
• A Study of INCB059872 in Relapsed or Refractory Ewing Sarcoma
• Pharmacologic Interaction Between Ifosfamide and Aprepitant in Treated Patients With Soft Tissue Sarcoma
• Vorinostat (SAHA) in Uterine Sarcoma
• High Dose Ascorbate With Preoperative Radiation in Patients With Locally Advanced Soft Tissue Sarcomas
• Vigil + Irinotecan and Temozolomide in Ewing's Sarcoma
• Apatinib for Advanced Sarcoma: Results From Multiple Institutions' Off-label Use
• Dose Escalation Study of CLR 131 in Children, Adolescents, and Young Adults With Relapsed or Refractory Malignant Tumors Including But Not Limited to Neuroblastoma, Rhabdomyosarcoma, Ewings Sarcoma, and Osteosarcoma
• A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors
• Phase II Multicentric Study of Pembrolizumab in Classic or Endemic Kaposi's Sarcoma
• Gemcitabine Plus Ascorbate for Sarcoma in Adults
• Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma
• Immunotherapy + Radiation in Resectable Soft Tissue Sarcoma
• CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced Cancers
• Modified T Cells, Chemotherapy, and Aldesleukin With or Without LV305 and CMB305 in Treating Participants With Advanced or Recurrent Sarcoma
• ADI-PEG 20 in Combination With Gemcitabine and Docetaxel for the Treatment of Soft Tissue Sarcoma, Osteosarcoma, Ewing's Sarcoma, and Small Cell Lung Cancer
• LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue Sarcomas
• Study to Assess Safety and Preliminary Activity of Eribulin Mesylate in Pediatric Participants With Relapsed/Refractory Rhabdomyosarcoma (RMS), Non-rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) and Ewing Sarcoma (EWS)
• Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors
• Treatment of Metastatic Soft Tissue Sarcoma (STS) Patients (FIBROSARC USA)
• FAZA PET/MRI Sarcoma
• Anlotinib and Irinotecan for Ewing Sarcoma
• A Study of Epacadostat, an IDO1 Inhibitor, in Combination With Pembrolizumab in Patients With Metastatic and/or Locally Advanced Sarcoma
• Immune Changes Following Trabectedin in Patients With Metastatic or Unresectable Sarcoma
• Irinotecan and Temozolomide for Ewing Sarcoma
• Study of the Safety, Pharmacokinetics and Efficacy of EDO-S101, in Patients With Advanced Solid Tumors
• Pegylated Liposomal Doxorubicin Versus Pirarubicin Plus Ifosfamide, Dacarbazine in Locally Advanced, Unresectable or Metastatic Soft-tissue Sarcoma
• Durvalumab and Tremelimumab Compared to Doxorubicin in Patients With Advanced or Metastatic Soft Tissue Sarcoma
• A Phase 2 Study of Pembrolizumab in Patients With Histiocyte/Dendritic Cell Neoplasms and Biologically Selected Subtypes of Relapsed/Refractory Aggressive Lymphomas
• Intra-lesional Nivolumab Therapy for Limited Cutaneous Kaposi Sarcoma
• Study of Neoadjuvant Checkpoint Blockade in Patients With Surgically Resectable Undifferentiated Pleomorphic Sarcoma and Dedifferentiated Liposarcoma
• Valganciclovir Four Weeks Prior to cART Initiation Compared to Standard Therapy for Disseminated Kaposi Sarcoma
• A Study of Olaratumab (LY3012207), Doxorubicin, and Ifosfamide in Participants With Advanced or Metastatic Soft Tissue Sarcoma
• A Study of NKTR-214 in Combination With Nivolumab in Patients With Metastatic and/or Locally Advanced Sarcoma
• Trial of Sunitinib Plus Nivolumab After Standard Treatment in Advanced Soft Tissue and Bone Sarcomas
• Trial of Nab-paclitaxel in Patients With Desmoid Tumors and Multiply Relapsed/Refractory Desmoplastic Small Round Cell Tumors and Ewing Sarcoma
• PLD and IFO As First-line Treatment for Patients With Advanced or Metastatic STS
• Study of TBI-1301 (NY-ESO-1 T Cell Receptor Gene Transduced Autologous T Lymphocytes) in Patients With Synovial Sarcoma
• Study Evaluating the Safety and Efficacy of Eribulin Mesilate in Combination With Irinotecan Hydrochloride in Children With Refractory or Recurrent Solid Tumors
• Low Molecular Weight Heparin (LMWH) vs Aspirin for Venous Thromboembolism (VTE) Prophylaxis in Orthopaedic Oncology
• Trial of Palbociclib in Second Line of Advanced Sarcomas With CDK4 Overexpression.
• A Study of Nivolumab in Selected Uterine Cancer Patients
• Genetically Engineered PBMC and PBSC Expressing NY-ESO-1 TCR After a Myeloablative Conditioning Regimen to Treat Patients With Advanced Cancer
• Testing Atezolizumab and Bevacizumab in People With Advanced Alveolar Soft Part Sarcoma
• Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial)
• Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial)
• Nivolumab and Ipilimumab in Classical Kaposi Sarcoma (CKS)
• MDM2 Inhibitor AMG-232 (KRT-232) and Radiation Therapy in Treating Patients With Soft Tissue Sarcoma
• Larotrectinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With NTRK Fusions (A Pediatric MATCH Treatment Trial)
• Samotolisib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial)
• Tazemetostat in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With EZH2, SMARCB1, or SMARCA4 Gene Mutations (A Pediatric MATCH Treatment Trial)
• Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial)
• Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial)
• Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain Cancers
• Dose-Escalation and Expansion Trial of NC-6300 in Patients With Advanced Solid Tumors or Soft Tissue Sarcoma
• Apatinib Second Line Treatment for Advanced Osteosarcoma and Soft Tissue Sarcomas ,Openting ,Single Center, One-armed Clinical Study.
• To Evaluate the Efficacy of NY-ESO-1-specific T Cell Receptor Affinity Enhancing Specific T Cell in Solid Tumors
• An Evaluation of Tc 99m Tilmanocept by Intravenous (IV) and Subcutaneous (SC) Injection in Kaposi Sarcoma (KS)
• Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)
• A Microdose Evaluation Study of ABY-029 in Primary Sarcoma
• Study of Nivolumab With or Without Pazopanib in Metastatic or Unresectable Soft Tissue Sarcomas
• Evaluation of Hyperbaric Oxygen Therapy on Wound Healing Following Management of Soft Tissue Sarcoma With Neo-Adjuvant Radiation and Surgical Resection
• Testing Atezolizumab and Bevacizumab in People With Advanced Alveolar Soft Part Sarcoma
• PAZIT Study for Children and Young Adults With Relapsed or Refractory Sarcoma
• SAINT:Trabectedin, Ipilimumab and Nivolumab as First Line Treatment for Advanced Soft Tissue Sarcoma
• QUILT-3.031: AMG 337 in Subjects With Advanced or Metastatic Clear Cell Sarcoma
• A Study of Olaratumab (LY3012207) Plus Pembrolizumab in Participants With Advanced or Metastatic Soft Tissue Sarcoma
• Pembrolizumab and Gemcitabine Chemotherapy in Leiomyosarcoma and Undifferentiated Pleomorphic Sarcoma
• Mesylate Apatinib for Stage Ⅳ STS After Failure of Chemotherapy
• Endostar Combined With Chemotherapy for Stage Ⅳ Soft Tissue Sarcoma
• Phase II Trial of Ribociclib and Everolimus in Advanced Dedifferentiated Liposarcoma (DDL) and Leiomyosarcoma (LMS)
• Study of Doxorubicin and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and Intraoperative Brachytherapy for Unresectable or Refractory Pelvic and Abdominal Rhabdomyosarcoma and Undifferentiated Sarcomas in Children
• Use of Propranolol Hydrochloride in the Treatment of Metastatic STS
• Apatinib for Advanced Soft Tissue Sarcoma Patients: a Phase 2, Multicenter Trial
• A Study Assessing Efficacy & Safety of Ribociclib in Patients With Advanced Well/Dedifferentiated Liposarcoma
• A Randomized Trial of Pembrolizumab & Radiotherapy Versus Radiotherapy in High-Risk Soft Tissue Sarcoma of the Extremity
• Trabectedin Combined With Durvalumab in Patients With Advanced Pretreated Soft-tissue Sarcomas and Ovarian Carcinomas.
• Nelfinavir Mesylate in Treating Patients With Kaposi Sarcoma
• A Study Evaluating MM-310 in Patients With Solid Tumors
• A Randomized Controlled Study Comparing Priming Solution Containing Crystalloid or Packed Red Blood Cells in Patients Treated With Isolated Limb Perfusion.
• A Study of Talimogene Laherparepvec (T-VEC) in Combination With Pembrolizumab in Patients With Metastatic and/or Locally Advanced Sarcoma
• Precise Local Injection of Anti-cancer Drugs Using Presage's CIVO Device in Soft Tissue Sarcoma
• Safety, Tolerability, and Efficacy of Doxorubicin and Pembrolizumab for Sarcoma
• Molecular-Functional Imaging of Hypoxia in Childhood Sarcomas
• Study of Selinexor and Doxorubicin in Advanced Soft Tissue Sarcomas
• A Phase I Clinical Study for Evaluating the Safety and Efficacy of MASCT-I in Patients With Advanced Solid Tumors
• Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)
• Ribociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot Be Removed by Surgery
• CBT-1® in Combination With Doxorubicin in Patients With Metastatic, Unresectable Sarcomas Who Previously Progressed on Doxorubicin
• Study of TAK-228 (MLN0128) in Soft Tissue Sarcomas
• Enoblituzumab (MGA271) in Children With B7-H3-expressing Solid Tumors
• A Phase II of Nivolumab Plus Ipilimumab in Non-resectable Sarcoma and Endometrial Carcinoma
• Sitravatinib in Advanced Liposarcoma and Other Soft Tissue Sarcomas
• Decitabine and Gemcitabine for Pancreatic Cancer and Sarcoma
• Efficacy of Ferric Carboxymaltose in Gastrointestinal Stromal Tumor (GIST) Patients With Iron Deficiency Anemia (IDA) Receiving Systemic Therapy
• Nab-Paclitaxel and Gemcitabine for Recurrent/Refractory Sarcoma
• Trabectedin Maintenance Post 1st-line in STS
• Trial of Intratumoral Injections of TTI-621 in Subjects With Relapsed and Refractory Solid Tumors and Mycosis Fungoides
• Pembrolizumab and Doxorubicin Hydrochloride in Treating Patients With Sarcoma That is Metastatic or Cannot Be Removed by Surgery
• Tazemetostat Rollover Study (TRuST): An Open-Label, Rollover Study
• Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
• Continuous 24h Intravenous Infusion of Mithramycin, an Inhibitor of Cancer Stem Cell Signaling, in People With Primary Thoracic Malignancies or Carcinomas, Sarcomas or Germ Cell Neoplasms With Pleuropulmonary Metastases
• Co-treatment With GnRH Analogs on the Ovarian Reserve in Young Women Treated With Alkylating Agents for Cancer
• Multi-Arm Study to Test the Efficacy of Immunotherapeutic Agents in Multiple Sarcoma Subtypes
• Ifosfamide, Doxorubicin and Hypofractionated Radiotherapy in Neoadjuvant Sarcoma Treatment
• In Vivo Lung Perfusion for Pulmonary Metastases of Sarcoma
• Ph II Nintedanib vs. Ifosfamide in Soft Tissue Sarcoma
• Targeting Microenvironment and Cellular Immunity in Sarcomas Weekly Trabectedin Combined With Metronomic Cyclophosphamide
• Study of the Pan-DAC Inhibitor AR-42 and Pazopanib in Advanced Sarcoma and Kidney Cancer
• Retrospective Study of Trabectedin in Soft Tissue Sarcomas
• A Study of Olaparib With Concomitant Radiotherapy in Locally Advanced/Unresectable Soft-tissue Sarcoma
• A Study of LY3039478 in Participants With Advanced or Metastatic Solid Tumors
• Response Based Treatment for Children With Unresectable Localized Soft Tissue Sarcoma
• A Study of Olaratumab (LY3012207) in Participants With Soft Tissue Sarcoma
• A Study of TB-403 in Pediatric Subjects With Relapsed or Refractory Medulloblastoma
• Rolapitant Hydrochloride in Preventing Nausea/Vomiting in Patients With Sarcoma Receiving Chemotherapy
• Protocol for the Treatment of Metastatic Ewing Sarcoma
• SARC021C: A Continuation Study of TH-CR-406/SARC021
• DHEA in Synovial Sarcoma Patients
• Trial Comparing Trabectedin to the Best Supportive Care in Patients With Sarcoma
• Pomalidomide in Combination With Liposomal Doxorubicin in People With Advanced or Refractory Kaposi Sarcoma
• A Study of Olaratumab (LY3012207) in Participants With Advanced Soft Tissue Sarcoma
• TK216 in Patients With Relapsed or Refractory Ewing Sarcoma
• Gene-Modified T Cells With or Without Decitabine in Treating Patients With Advanced Malignancies Expressing NY-ESO-1
• Axitinib and Pembrolizumab in Subjects With Advanced Alveolar Soft Part Sarcoma and Other Soft Tissue Sarcomas
• A Study of LY2880070 in Participants With Advanced or Metastatic Cancer
• A Study of Metronomic CP and JX-594 in Patients With Advanced Breast Cancer and Advanced Soft-tissue Sarcoma (METROmaJX)
• Study of Genistein in Pediatric Oncology Patients (UVA-Gen001)
• Pharmacokinetic Study of PM01183 in Combination With Irinotecan in Patients With Selected Solid Tumors
• A Phase II, Multicenter Study of the EZH2 Inhibitor Tazemetostat in Adult Subjects With INI1-Negative Tumors or Relapsed/Refractory Synovial Sarcoma
• A Phase 1 Study of the EZH2 Inhibitor Tazemetostat in Pediatric Subjects With Relapsed or Refractory INI1-Negative Tumors or Synovial Sarcoma
• Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma
• PLX3397 Plus Sirolimus in Unresectable Sarcoma and Malignant Peripheral Nerve Sheath Tumors
• Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma
• Clinical Study of Concurrent Pazopanib and Radiotherapy for Non-metastatic Sarcoma Patients
• A Dose Escalation Study Of PF-06801591 In Melanoma, Head And Neck Cancer (SCCHN), Ovarian, Sarcoma, Non-Small Cell Lung Cancer, Urothelial Carcinoma or Other Solid Tumors
• A Phase II Study Assessing Efficacy & Safety of Ribociclib in Patients With Advanced Well/Dedifferentiated Liposarcoma
• Compassionate Use of Aldoxorubicin in Sarcoma Patients Chemotherapy
• Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)
• ABBV-085, an Antibody Drug Conjugate, in Subjects With Advanced Solid Tumors
• HIFU Hyperthermia With Liposomal Doxorubicin (DOXIL) for Relapsed or Refractory Pediatric and Young Adult Solid Tumors
• Eurosarc Trial of Linsitinib in Advanced Ewing Sarcoma
• A Phase I Study of Lyso-thermosensitive Liposomal Doxorubicin and MR-HIFU for Pediatric Refractory Solid Tumors
• A Study of Lenalidomide for Adult Histiocyte Disorders
• A Two-part Phase IIb Trial of Vigil in Ewing's Sarcoma
• Trabectedin and Irinotecan for Refractory Pediatric Sarcomas
• Isolated Limb Perfusion With Melphalan in Treating Patients With Stage IIIB-IV Melanoma or Sarcoma
• Dendritic Cell-based Immunotherapy for Advanced Solid Tumours of Children and Young Adults
• CPI-613, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Granulocytic Sarcoma
• Study To Examine Toxicity Of Allogeneic Stem Cell Transplantation For Relapsed Or Therapy Refractory Ewings Sarcoma
• Safety Study of BLZ-100 in Adult Subjects With Sarcoma Undergoing Surgery
• TVEC and Preop Radiation for Sarcoma (4 ml Dose)
• A Study of Doxorubicin Plus Olaratumab (LY3012207) in Participants With Advanced or Metastatic Soft Tissue Sarcoma
• Study of Anlotinib in Patients With Soft Tissue Sarcoma（STS）(ALTER0203)
• A Phase II Multi-Strata Study of PM01183 as a Single Agent or in Combination With Conventional Chemotherapy in Metastatic and/or Unresectable Sarcomas
• Three Versus Five Years of Adjuvant Imatinib as Treatment of Patients With Operable GIST
• Combination of MK3475 and Metronomic Cyclophosphamide in Patients With Advanced Sarcomas : Multicentre Phase II Trial
• Trabectedin Plus Olaparib in Metastatic or Advanced Sarcomas (TOMAS)
• Simvastatin With Topotecan and Cyclophosphamide in Relapsed and/or Refractory Pediatric Solid and CNS Tumors
• A Phase II Study Evaluating Efficacy and Safety of Regorafenib in Patients With Metastatic Bone Sarcomas
• Real-Time Contrast-Enhanced Ultrasonography and Shear Wave Elastography in Predicting Treatment Response in Patients With Soft Tissue Sarcoma
• Efficacy and Safety of Trabectedin (Yondelis®) in Patients With Advanced Soft Tissue Sarcoma
• Study of Pazopanib Versus Placebo as Maintenance Therapy for Advanced Soft Tissue Sarcoma
• Hyper-Thermia Enhanced Anti-tumor Efficacy of Trabectedin
• Pazopanib Hydrochloride and Topotecan Hydrochloride in Treating Patients With Metastatic Soft Tissue and Bone Sarcomas
• A Study of Olaratumab and Doxorubicin in Participants With Advanced Soft Tissue Sarcoma
• Combination Chemotherapy With or Without Ganitumab in Treating Patients With Newly Diagnosed Metastatic Ewing Sarcoma
• SARC028: A Phase II Study of the Anti-PD1 Antibody Pembrolizumab (MK-3475) in Patients With Advanced Sarcomas
• Pazopanib as Front-Line Therapy in Patients With Non-Resectable or Metastatic Soft Tissue Sarcomas Who Are Not Candidates for Chemotherapy
• Trabectedin Plus Radiotherapy in Soft Tissue Sarcoma Patients
• Efficacy and Safety Study of GPX-150 to Treat Soft Tissue Sarcoma
• A Japanese Trial of TH-302 in Subjects With Locally Advanced Unresectable or Metastatic Soft Tissue Sarcoma
• Cabozantinib S-malate in Treating Patients With Relapsed Osteosarcoma or Ewing Sarcoma
• Study to Investigate the Safety and Activity of Aldoxorubicin Plus Ifosfamide/Mesna in Subjects With Metastatic Soft Tissue Sarcoma
• Early Phase Evaluation of ABC294640 in Patients With Refractory/Relapsed Diffuse Large B-cell Lymphoma or Kaposi Sarcoma
• Phase II Multicentric Study of Digoxin Per os in Classic or Endemic Kaposi' s Sarcoma
• Adoptive Therapy Using Antigen-Specific CD4 T-Cells
• Pazopanib Maintenance Phase II
• Evaluation of Tc 99m Tilmanocept Localization in Primary Cutaneous Kaposi's Sarcoma and Lymphatic Drainage by SPECT/CT
• Ganetespib and Ziv-Aflibercept in Refractory Gastrointestinal Carcinomas, Non-Squamous Non-Small Cell Lung Carcinomas, Urothelial Carcinomas, and Sarcomas
• α-TEA in Advanced Cancer
• Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery
• TLR4 Agonist GLA-SE and Radiation Therapy in Treating Patients With Soft Tissue Sarcoma That Is Metastatic or Cannot Be Removed by Surgery
• Medical Safety Follow-up Study for Patients Who Received More Than 28 Days of Total Exposure to BGG492
• Gamma Secretase Inhibitor PF-03084014 in Treating Patients With AIDS-Associated Kaposi Sarcoma
• Pazopanib for Metastatic Alveolar Soft Part Sarcoma
• A Phase I Trial of T Cells Expressing an Anti-GD2 Chimeric Antigen Receptor in Children and Young Adults With GD2+ Solid Tumors
• Phase 2 STIR Trial: Haploidentical Transplant and Donor Natural Killer Cells for Solid Tumors
• Nelfinavir for the Treatment of Gammaherpesvirus-Related Tumors
• L19TNFα in Combination With Doxorubicin in Patients With Advanced Solid Tumours
• Trabectedin First Line Therapy In Unfit Sarcoma Study
• Efficacy of Dose Intensification in Patients With Non-metastatic Ewing Sarcoma
• NY-ESO-1 Specific T Cells After Cyclophosphamide in Treating Patients With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma
• Adjuvant Tumor Lysate Vaccine and Iscomatrix With or Without Metronomic Oral Cyclophosphamide and Celecoxib in Patients With Malignancies Involving Lungs, Esophagus, Pleura, or Mediastinum
• Sorafenib Tosylate, Combination Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With High-Risk Stage IIB-IV Soft Tissue Sarcoma
• Phase 3 Study to Treat Patients With Soft Tissue Sarcomas
• Daily Oral Regorafenib for Chemotherapy-Refractory, Metastatic and Locally Advanced Angiosarcoma
• SARC024: A Blanket Protocol to Study Oral Regorafenib in Patients With Selected Sarcoma Subtypes
• PP-Gemcitabine & External Beam Radiation-Sarcomas
• ESP1/SARC025 Global Collaboration: A Phase I Study of a Combination of the PARP Inhibitor, Niraparib and Temozolomide and/or Irinotecan Patients With Previously Treated, Incurable Ewing Sarcoma
• A Study to Investigate ALDOXORUBICIN in HIV-infected Subjects With Kaposi's Sarcoma
• Will Glucarpidase After Methotrexate Treatment for Bone Sarcoma Lead to Fewer Side Effects and Reduce Chemotherapy Delays?
• Mifepristone and Eribulin in Patients With Metastatic Triple Negative Breast Cancer or Other Specified Solid Tumors
• SARC023: Ganetespib and Sirolimus in Patients With MPNST (Malignant Peripheral Nerve Sheath Tumors)
• Individualizing Pazopanib Therapy by exploRing the Role of Early Metabolic responsE and Drug Exposure as a preDICTor for Treatment Outcome in Patients With STS
• Combined Modality Treatment of Sarcomas of the Extremities
• IRCI Gynae Sarcomas, High Grade Uterine Sarcoma
• A Phase 1B Dose-escalation and Phase 2a Study of Carotuximab (TRC105) in Combination With Pazopanib in Patients With Advanced Soft Tissue Sarcoma
• A Phase I Study to Examine the Toxicity of Allogeneic Stem Cell Transplantation for Relapsed or Therapy Refractory Ewing Sarcoma
• Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors
• Gemcitabine Hydrochloride, Docetaxel, and Radiation Therapy in Treating Patients With Uterine Sarcoma That Has Been Removed By Surgery
• iC9-GD2-CAR-VZV-CTLs/Refractory or Metastatic GD2-positive Sarcoma and Neuroblastoma
• Therapeutic Trial for Patients With Ewing Sarcoma Family of Tumor and Desmoplastic Small Round Cell Tumors
• Isolated Limb Perfusion of Melphalan for Melanoma and Sarcoma Treatment
• Phase II Study of Regorafenib in Metastatic Soft Tissue Sarcoma
• A Phase I Trial to Assess the Effects of Food and Formulation on PK of KPT-330 in Patients With Sarcoma
• Phase 1b/2 Study of Vorinostat in Combination With Gemcitabine and Docetaxel in Advanced Sarcoma
• Irinotecan and Temozolomide in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Patients With Newly Diagnosed Ewing Sarcoma
• A Trial Comparing Two Medications as First Treatment in Elderly Patients With Metastatic or Advanced Soft Tissue Sarcoma
• Phase I Study of Olaparib and Temozolomide for Ewings Sarcoma or Rhabdoomyosarcoma
• A Phase II Trial of Combined Hydroxychloroquine and Sirolimus in Soft Tissue Sarcoma
• Phase I Dose Escalation of Monthly Intravenous Ra-223 Dichloride in Osteosarcoma
• RAD001 in Advanced Sarcoma
• 18F-FLT Positron Emission Tomography and Diffusion-Weighted Magnetic Resonance Imaging in Planning Surgery and Radiation Therapy and Measuring Response in Patients With Newly Diagnosed Ewing Sarcoma
• Endostar + GT in Pulmonary Metastases of Soft Tissue Sarcoma
• Dendritic Cell Vaccine for Children and Adults With Sarcoma
• Whole-Body Radiation Therapy, Systemic Chemotherapy, and High-Dose Chemotherapy Followed By Stem Cell Rescue in Treating Patients With Poor-Risk Ewing Sarcoma
• A Phase II Study of Tivozanib in Patients With Metastatic and Non-resectable Soft Tissue Sarcomas
• Cabozantinib for Adults With Advanced Soft Tissue Sarcoma
• A Study of Selumetinib in Patients With Kaposi's Sarcoma
• Bevacizumab/Doxorubicin/Radiation for Sarcoma
• Study of ENMD-2076 in Patients With Advanced/Metastatic Soft Tissue Sarcoma
• Docetaxel, Gemcitabine and Pazopanib as Treatment for Soft Tissue Sarcoma
• Clinical Study of Metronomic Oral Cyclophosphamide in Patients With Advanced Sarcomas
• Localized High-Risk Soft Tissue Sarcomas Of The Extremities And Trunk Wall In Adults: An Integrating Approach Comprising Standard Vs Histotype-Tailored Neoadjuvant Chemotherapy
• Aspirin and Compression Devices for VTE Prophylaxis in Orthopaedic Oncology
• Study of Intensive Chemotherapy, Surgery and Radiotherapy to Treat Ewing's Sarcoma in Children and Young Adults
• Gemcitabine Plus Rapamycin Versus Gemcitabine to Treat Advanced Soft Tissue Sarcoma
• Ferumoxytol-Enhanced MRI in Adult/Pedi Sarcomas
• Study of 124I-NM404 in Advanced Solid Malignancies
• SARC016: Study of Everolimus With Bevacizumab to Treat Refractory Malignant Peripheral Nerve Sheath Tumors
• Alisertib in Treating Patients With Advanced or Metastatic Sarcoma
• Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological Cancer
• Dasatinib and Ipilimumab in Treating Patients With Gastrointestinal Stromal Tumors or Other Sarcomas That Cannot Be Removed by Surgery or Are Metastatic
• Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction
• Cathepsin Activatable Fluorescent Probe
• Cixutumumab and Temsirolimus in Treating Younger Patients With Recurrent or Refractory Sarcoma
• Mithramycin for Children and Adults With Solid Tumors or Ewing Sarcoma
• A Study of RO5045337 in Combination With Doxorubicin in Patients With Soft Tissue Sarcoma
• A Phase II Trial Comparing Gemcitabine and Pazopanib Versus Gemcitabine and Docetaxel for Patients With Advanced Soft Tissue Sarcoma
• Aerosol IL-2 for Pulmonary Metastases
• Olaparib in Adults With Recurrent/Metastatic Ewing's Sarcoma
• Sarcoma Study of MORAb-004 Utilization: Research and Clinical Evaluation
• Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By Surgery
• Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease
• Trebananib And Temsirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
• Study of Preoperative Therapy With Pazopanib (Votrient®) to Treat High-risk Soft Tissue Sarcoma
• Gemcitabine With or Without Pazopanib in Treating Patients With Refractory Soft Tissue Sarcoma
• CREATE: Cross-tumoral Phase 2 With Crizotinib
• Dose Escalation Study of Sorafenib and Irinotecan Combination Therapy in Pediatric Patients With Solid Tumors
• Preliminary Efficacy and Safety of INNO-206 Compared to Doxorubicin in Advanced Soft Tissue Sarcoma
• Auto Transplant for High Risk or Relapsed Solid or CNS Tumors
• Safety Study of Preoperative Sunitinib and Radiation in Soft Tissue Sarcoma
• Pomalidomide for Kaposi Sarcoma in People With or Without HIV
• Cyclophosphamide, Topotecan, and Bevacizumab (CTB) in Patients With Relapsed/Refractory Ewing's Sarcoma and Neuroblastoma
• Eltrombopag for the Prevention of Chemotherapy Induced Thrombocytopenia
• Fosaprepitant in Patients Receiving Ifosfamide-based Regimen
• Evaluation of 64Cu-DOTA-U3-1287 in Subjects With Advanced Solid Tumors
• Autologous T Cells and Cyclophosphamide in Treating Patients With Soft Tissue Sarcoma That is Metastatic or Cannot Be Removed By Surgery
• First in Man Study Investigating the Biodistribution, the Safety and Optimal Recommended Dose of a New Radiolabelled Monoclonal Antibody Targeting Frizzled Homolog 10
• Pazopanib and ARQ 197 for Advanced Solid Tumors
• Pazopanib Hydrochloride in Treating Patients With Advanced Angiosarcoma
• An Open-label, Multicenter, Phase 2 Study to Evaluate the Efficacy and Safety of Eribulin Mesylate in Previously Treated Subjects With Advanced or Metastatic Soft Tissue Sarcoma (Study E7389-J081-217)
• Pazopanib Hydrochloride Followed by Chemotherapy and Surgery in Treating Patients With Soft Tissue Sarcoma
• Phase I Study of Ipilimumab (Anti-CTLA-4) in Children and Adolescents With Treatment-Resistant Cancer
• A Trial of TH-302 in Combination With Doxorubicin Versus Doxorubicin Alone to Treat Patients With Locally Advanced Unresectable or Metastatic Soft Tissue Sarcoma
• Phase 1 Study of Pazopanib With GSK1120212 in Advanced Solid Tumors, Enriched With Patients With Differentiated Thyroid Cancer, Soft-tissue Sarcoma, and Cholangiocarcinoma
• YONDELIS (Trabectedin) Single Patient Compassionate Use / Expanded Access
• Gemcitabine and Docetaxel in Combination With Pazopanib (Gem/Doce/Pzb) for the Neoadjuvant Treatment of Soft Tissue Sarcoma (STS)
• NHS-IL12 for Solid Tumors
• A Phase II Study With Tumor Molecular Pharmacodynamic (MPD) Evaluation of Oral mTOR-inhibitor Everolimus (RAD001) 10 mg Daily in Patients Suffering From Classic or Endemic Kaposi's Sarcoma
• HYPAZ: Hypertension Induced by Pazopanib
• Sunitinib or Cediranib for Alveolar Soft Part Sarcoma
• CT-011 and p53 Genetic Vaccine for Advanced Solid Tumors
• Neoadjuvant and Adjuvant Chemotherapy in High-risk Soft Tissue Sarcoma
• Trial of Docetaxel and Irinotecan (DI) for Recurrent or Refractory Bone and Soft Tissue Sarcomas.
• Doxorubicin With or Without Sildenafil, With Analysis of Cardiac Markers
• Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With Uterine Cancer
• Antiretroviral Therapy (ART) Alone or With Delayed Chemo Versus ART With Immediate Chemo for Limited AIDS-related Kaposi's Sarcoma
• Tumor Cell Vaccines and ISCOMATRIX With Chemotherapy After Tumor Removal
• A Trial of Cediranib in the Treatment of Patients With Alveolar Soft Part Sarcoma (CASPS)
• Differentiation of Bone Sarcomas and Osteomyelitis With Ferumoxytol-Enhanced MRI
• Aflac ST0901 CHOANOME - Sirolimus in Solid Tumors
• Phase 3 Study to Compare the Efficacy and Safety of Eribulin With Dacarbazine in Subjects With Soft Tissue Sarcoma
• Cyclophosphamide, Doxorubicin, Vincristine w/ Irinotecan and Temozolomide in Ewings Sarcoma
• Tumor Cell Vaccine for Patients Undergoing Surgery for Sarcomas, Melanomas, Germ Cell Tumors, or Malignancies That Have Metastasized to the Lungs, Pleura, or Mediastinum
• Study of Continuous Dosing of Sunitinib in Non GIST Sarcomas With Concomitant Radiotherapy
• Continuing vs Intermittent Trabectedin in Patients With Advanced Soft Tissue Sarcoma
• Intralesional Bevacizumab for Treating AIDS-associated Kaposi´s Sarcoma of the Larynx, Pharynx and Oral Cavity
• Study of Oral Ridaforolimus in Combination With Standard Chemotherapy for Soft Tissue Sarcoma
• Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors
• A Combined Study in Pediatric Cancer Patients for Dose Ranging and Efficacy/Safety of Plerixafor Plus Standard Regimens for Mobilization Versus Standard Regimens Alone
• Everolimus in Combination With Imatinib Mesylate in Treating Patients With Locally Advanced, Locally Recurrent, or Metastatic Soft Tissue Sarcoma
• Effects of Maraviroc (MVC) on HIV-related Kaposi's Sarcoma (KS)
• Dose Escalation Study of TriN2755 in Advanced Solid Tumors and Sarcomas
• Amrubicin Chemotherapy as First Line in Metastatic or Unresectable Soft Tissue Sarcoma
• Tumor Cell Vaccines With ISCOMATRIX Adjuvant and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers and Malignant Pleural Mesotheliomas
• Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma
• To Evaluate the Safety, Activity and Pharmacokinetics of Marqibo in Children and Adolescents With Refractory Cancer
• Study of Zalypsis® (PM00104) in Patients With Unresectable Locally Advanced and/or Metastatic Ewing Family of Tumors (EFT) Progressing After at Least One Prior Line of Chemotherapy
• Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory Rhabdomyosarcoma
• Phase II Study of Everolimus in Children and Adolescents With Refractory or Relapsed Rhabdomyosarcoma and Other Soft Tissue Sarcomas
• Selumetinib With or Without Temsirolimus in Treating Patients With Metastatic, Recurrent, or Locally Advanced Soft Tissue Sarcoma That Cannot Be Removed By Surgery
• Temsirolimus and Valproic Acid in Treating Young Patients With Relapsed Neuroblastoma, Bone Sarcoma, or Soft Tissue Sarcoma
• Gemcitabine,Vincristine and Cisplatin as Second Line Combination Therapy in Patients With Sarcoma
• Doxorubicin Hydrochloride or Trabectedin in Treating Patients With Previously Untreated Advanced or Metastatic Soft Tissue Sarcoma
• A Study of Olaratumab in Soft Tissue Sarcoma
• Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors in Pediatric Patients
• Study of Palifosfamide-tris in Combination With Doxorubicin in Patients With Front-line Metastatic Soft Tissue Sarcoma
• Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors
• Alisertib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia
• Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma
• Pilot Study of Allogeneic Tumor Cell Vaccine With Metronomic Oral Cyclophosphamide and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers, Thymic Neoplasms, and Malignant Pleural Mesotheliomas
• A Study of Axitinib in Patients With Advanced Angiosarcoma and Other Soft Tissue Sarcomas
• Efficacy and Safety Assessment of Oral LBH589 in Adult Patients With Advanced Soft TIssue Sarcoma After Pre-treatment Failure
• A Phase I Study of Vorinostat and Bortezomib in Children With Refractory of Recurrent Solid Tumors, Including CNS Tumors and Lymphomas
• A Phase I Study of Pazopanib as a Single Agent for Children With Refractory Solid Tumors
• A Study of SB939 in Patients With Translocation-Associated Recurrent/Metastatic Sarcomas
• Bevacizumab, Chemotherapy and Valproic Acid in Advanced Sarcomas
• Doxorubicin vs. Trabectedin Plus Doxorubicin in Non Operable and/or Metastatic STS
• Neoadyuvant High-dose of Ifosfamide and Concurrent Radiotherapy in Soft Tissue Sarcoma
• Pharmacokinetic Study of Doxorubicin in Children With Cancer
• Treatment With Indinavir and Chemotherapy for Advanced Classical Kaposi's Sarcoma
• Lenalidomide in Treating Patients With AIDS-Associated Kaposi's Sarcoma
• Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
• Paclitaxel + Bevacizumab (Avastin) for the Treatment of Metastatic or Unresectable Angiosarcoma
• Study of RAD001 in Soft Tissue Extremity and/or Retroperitoneal Sarcomas
• PCI-24781 in Combination With Doxorubicin to Treat Sarcoma
• Bortezomib in Treating Patients With Relapsed or Refractory AIDS-Related Kaposi Sarcoma
• Temsirolimus and Cixutumumab in Treating Patients With Locally Advanced, Metastatic, or Recurrent Soft Tissue Sarcoma or Bone Sarcoma
• Cisplatin in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer or Lung Metastasis
• Study of Pazopanib and Ixabepilone in Patients With Solid Tumors
• Gemcitabine Hydrochloride and Docetaxel With or Without Bevacizumab in Treating Patients With Advanced or Recurrent Uterine Leiomyosarcoma
• Adjuvant Valproate for High Grade Sarcomas
• Phase II Study of Ridaforolimus (MK-8669) With Metastatic Bone or Soft-tissue Sarcoma Patients (MK-8669-030 AM1)
• Study of Panobinostat in Combination With Sorafenib in Kidney, Soft Tissue or Lung Cancers
• Phase I/II Study of Irinotecan and Temsirolimus in Patients With Refractory Sarcomas
• Study in Localized and Disseminated Ewing Sarcoma
• Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity Cancer
• Safety and Efficacy Study of Torisel and Liposomal Doxorubicin for Patients With Recurrent Sarcoma
• Phase II Study of Cediranib (AZD2171) in Patients With Alveolar Soft Part Sarcoma
• Vorinostat and Bortezomib in Treating Patients With Advanced Soft Tissue Sarcoma
• Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment
• RAD001 in Combination With CP-751,871 in Patients Wtih Advanced Sarcomas and Other Malignant Neoplasms
• Pilot Study of Liposomal Doxorubicin Combined With Bevacizumab Followed by Bevacizumab Monotherapy in Adults With Advanced Kaposi s Sarcoma
• Therapy to Treat Ewing's Sarcoma, Rhabdomyosarcoma or Neuroblastoma
• Study on Efficacy and Tolerability of Vorinostat in Patients With Advanced, Metastatic Soft Tissue Sarcoma (STS)
• Her2 Chimeric Antigen Receptor Expressing T Cells in Advanced Sarcoma
• EF5 to Evaluate Tumor Hypoxia in Patients With High-Grade Soft Tissue Sarcoma or Mouth Cancer
• Gemcitabine and Docetaxel With Bevacizumab in Selected Sarcoma Subtypes
• Proton Chemoradiotherapy for High-Risk Soft Tissue Sarcomas
• Sorafenib and Ifosfamide in Treating Patients With High-Grade Soft Tissue Sarcoma or Bone Sarcoma That Can Be Removed by Surgery
• A Phase I/II Clinical Trial of PXD101 in Combination With Doxorubicin in Patients With Soft Tissue Sarcomas
• Trial for Localised High-risk Rhabdomyosarcoma and Rhabdomyosarcoma-like Soft Tissue Sarcoma
• Sorafenib in Treating Patients With Angiosarcoma That is Locally Advanced, Metastatic, or Unable to Be Removed by Surgery
• Trial of Neoadjuvant Conformal Radiotherapy Plus Sorafenib for Patients With Soft Tissue Sarcoma of the Extremity and Body Wall
• Alimta Plus Gemcitabine for Advanced Sarcoma
• Sunitinib in Certain Subtypes of Soft Tissue Sarcomas
• Topotecan in Treating Patients With Gynecologic Cancer That Cannot Be Removed by Surgery
• Sorafenib and Dacarbazine in Soft Tissue Sarcoma
• A Pilot Study Of the Effects of Highly Active Antiretroviral Therapy on Kaposi's Sarcoma in Zimbabwe
• Sorafenib, Epirubicin, Ifosfamide, and Radiation Therapy Followed By Surgery in Treating Patients With High-Risk Stage II or Stage III Soft Tissue Sarcoma
• Multicenter Trial With PegLiposomal Doxorubicin and Carboplatin Combination Chemotherapy in Gynecological Sarcomas and Mixed Epithelial-Mesenchymal Tumors
• Weekly Docetaxel and Fixed-Dose Rate Gemcitabine Combination Chemotherapy
• Dacarbazine for Metastatic Soft Tissue and Bone Sarcoma
• An Efficacy and Safety Study of Trabectedin Versus Doxorubicin-Based Chemotherapy in Participants With Translocation-Related Sarcomas (TRS)
• A Scandinavian Sarcoma Group Protocol for Patients With High-risk Soft Tissue Sarcoma of the Extremities and Trunk Wall
• Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors
• Treatment of Patients With RAD001 With Progressive Sarcoma
• Phase II Study of Doxorubicin and Avastin® in Sarcoma.
• Sunitinib and Radiation in Patients With Resectable Soft-tissue Sarcoma
• Pazopanib Versus Placebo in Patients With Soft Tissue Sarcoma Whose Disease Has Progressed During or Following Prior Therapy
• A Phase II Study of Oral Cyclophosphamide and Sirolimus (OCR) in Advanced Sarcoma
• Exploratory, Phase 0 Study of Positron Emission Tomography (PET) Imaging Agent, F-18 RGD-K5
• Dose-Escalation Study of TH-302 in Combination With Doxorubicin to Treat Patients With Advanced Soft Tissue Sarcoma
• Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma
• A Study of Palifosfamide Tris Plus Doxorubicin Versus Doxorubicin in Unresectable or Metastatic Soft-tissue Sarcoma
• Efficacy and Safety Study of CC-4047 (Pomalidomide) to Treat Advanced Soft Tissue Sarcoma
• A Study of AVE8062 in Advanced-stage Soft Tissue Sarcoma After Failure of Anthracycline and Ifosfamide Chemotherapies
• PTC299 in Treating Patients With HIV-Related Kaposi Sarcoma
• Combination Chemotherapy in Treating Patients With Sarcoma
• AZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue Sarcoma
• Combination Chemotherapy, Radiation Therapy, and Sargramostim Before and After Surgery in Treating Patients With Soft Tissue Sarcoma That Can Be Removed By Surgery
• A Study of Avastin (Bevacizumab) in Combination With Standard Chemotherapy in Children and Adolescents With Sarcoma.
• A Study of R1507 in Participants With Recurrent or Refractory Sarcoma
• Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor
• Phase II Study of Brivanib (BMS-582664) to Treat Multiple Tumor Types
• Phase I Dose-Escalation Study Of Azacitidine In Combination With Temozolomide
• Phase 1b/2 Study of AMG 655 With Doxorubicin for the First-Line Treatment of Unresectable Soft Tissue Sarcoma
• MT2004-30: Tomotherapy for Solid Tumors
• Bortezomib and Cetuximab in Treating Patients With Advanced Solid Tumors
• Two Regimens of Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed Localized Ewing Sarcoma Family of Tumors
• Image-Guided Radiation Therapy in Treating Patients With Primary Soft Tissue Sarcoma of the Shoulder, Arm, Hip, or Leg
• Safety Study of Dacarbazine and Bortezomib in Melanoma and Soft Tissue Sarcoma
• Study on VCD/IE in the Patients With Ewing's Sarcoma Family of Tumors (ESFT)
• A Proof-of-concept Study to Assess the Ability of [18F]AH-111585 PET Imaging to Detect Tumours and Angiogenesis
• QUILT-3.025: A Phase 2 Study of AMG 479 in Relapsed or Refractory Ewing's Family Tumor and Desmoplastic Small Round Cell Tumors
• Study Of CP-751,871 In Patients With Ewing's Sarcoma Family Of Tumors
• Phase 2 Study in Patients With MiT Tumors
• Combination Chemotherapy and Dexrazoxane Followed by Surgery and Radiation Therapy in Treating Patients With Advanced Soft Tissue Sarcoma or Recurrent Bone Sarcoma
• Phase I-II Trial of Sorafenib in Combination With Ifosfamide in Soft Tissue Sarcoma
• Phase II Pilot Study of Vincristine, Adriamycin, Actinomycin D, Ifosfamide Combination Chemotherapy in Ewing's Sarcoma
• Ridaforolimus in Treatment of Sarcoma-SUCCEED (Sarcoma Multi-Center Clinical Evaluation of the Efficacy of Ridaforolimus)(8669-011 AM6)
• High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors
• BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors
• Dalteparin in Preventing DVT in Participants With Cancer
• Sunitinib Malate in Treating East African Patients With Kaposi Sarcoma
• Vincristine Sulfate, Topotecan Hydrochloride, and Cyclophosphamide With or Without Bevacizumab in Treating Young Patients With Refractory or First Recurrent Extracranial Ewing Sarcoma
• High-Dose Methotrexate in Treating Young Patients With Solid Tumors
• Irinotecan (Camptosar) in Patients With Advanced Sarcomas
• Post-Operative Chemoradiation for Extremity & Trunk Soft Tissue Sarcoma
• Aerosol L9-NC and Temozolomide in Ewing's Sarcoma
• A Study of LY573636-Sodium in the Treatment of Patients With Metastatic Soft Tissue Sarcoma
• Phase II Study of NGR-hTNF in Combination With Doxorubicin in Patients Affected by Soft Tissue Sarcomas.
• Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas
• Cytarabine in Treating Young Patients With Recurrent or Refractory Ewing's Sarcoma
• Trial of Dasatinib in Advanced Sarcomas
• Celecoxib and Radiation Therapy in Treating Patients With Stage II or Stage III Soft Tissue Sarcoma of the Arm, Hand, Leg, or Foot That Has Been Removed by Surgery
• Sirolimus in Treating Patients With HIV-Related Kaposi's Sarcoma
• Anti-Retrovirals for Kaposi's Sarcoma
• Safety and Efficacy Study of Glufosfamide in Previously Treated Advanced Soft Tissue Sarcoma
• Study of ZIO-201 in Advanced Sarcoma
• Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin for Children With Peritoneal Cancer
• HGS-ETR2 to Treat Children With Solid Tumors
• Pemetrexed in Patients With Soft Tissue Sarcoma
• Liposomal Daunorubicin in Treating Patients With HIV-Related Kaposi's Sarcoma
• E7389 Administered as an IV Bolus Infusion Day 1 and Day 8 Every 3 Weeks in Pre-Treated Patients With Advanced and/or Metastatic Soft Tissue Sarcoma
• Palonosetron in Sarcoma Patients Receiving Chemotherapy With Adriamycin and Ifosfamide (AI)
• Brostallicin or Doxorubicin as First-Line Therapy in Treating Patients With Relapsed, Refractory, or Metastatic Soft Tissue Sarcoma
• BAY-43-9006 in Advanced, Metastatic Soft Tissue Sarcomas
• A Trial of Perifosine in Patients With Chemo-Insensitive Sarcomas
• Phase II Study of Sunitinib Malate for Metastatic and/or Surgically Unresectable Soft Tissue Sarcoma
• Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma
• The Biological Activity of Cediranib (AZD2171) in Gastro-Intestinal Stromal Tumours(GIST).
• Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic Cancer
• HIV/AIDS Kaposis Sarcoma: Comparison of Response to HAART vs HAART Plus CXT
• Combination Chemotherapy in Treating Young Patients With Nonmetastatic Rhabdomyosarcoma
• Trabectedin in Treating Patients With Advanced, Persistent, or Recurrent Leiomyosarcoma of the Uterus
• Glutamine in Treating Neuropathy Caused by Vincristine in Young Patients With Lymphoma, Leukemia, or Solid Tumors
• Treatment of Classical Non-HIV-Related Kaposi's Sarcoma With the Antiviral Drug Indinavir
• Phase II Trial of Locally Advanced/Metastatic Soft Tissue Sarcoma or Advanced/Metastatic Malignant GIST
• Dose Finding Study Of Oral Eltrombopag In Patients With Sarcoma Receiving Adriamycin And Ifosfamide
• Busulfan, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk Ewing's Tumors
• Bevacizumab and Radiation Therapy for Sarcomas
• Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma
• High-Dose Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Metastatic Rhabdomyosarcoma or Ectomesenchymoma
• Polyvinylpyrrolidone-Sodium Hyaluronate Gel in Reducing Pain From Oral Mucositis in Young Patients With Cancer
• Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
• PET CT as Predictor of Response in Preoperative Chemotherapy for Soft Tissue Sarcoma
• Glutamine in Preventing Oral Mucositis in Patients Receiving Chemotherapy for Sarcoma
• Combination Chemotherapy With or Without Topotecan in Treating Patients With Newly Diagnosed Localized Ewing's Sarcoma
• Ifosfamide and Doxorubicin, Radiation Therapy, and/or Surgery in Treating Young Patients With Localized Soft Tissue Sarcoma
• Ixabepilone in Treating Young Patients With Refractory Solid Tumors
• Sorafenib in Treating Patients With Soft Tissue Sarcomas (Extremity Sarcoma Closed to Entry as of 5/30/07)
• Combination Chemotherapy in Treating Patients With Stage III or Stage IV Malignant Peripheral Nerve Sheath Tumors
• Talabostat Combined With Temozolomide or Carboplatin in Treating Young Patients With Relapsed or Refractory Brain Tumors or Other Solid Tumors
• Pazopanib In Patients With Relapsed Or Refractory Soft Tissue Sarcoma
• Nicotine Skin Patch in Treating Patients With Kaposi's Sarcoma
• Epidural Analgesia or Patient-Controlled Analgesia in Treating Patients Who Have Undergone Surgery for Gynecologic Cancer
• TLC D-99 and Ifosfamide in Metastatic Soft Tissue Sarcoma Patients
• Interaction of Docetaxel and Lonafarnib in Patients With Advanced Cancer
• Safety, Tolerability and Maximum Tolerated Dose of Oral AP23573 in Combination With Doxorubicin (8669-015)
• Docetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic Cancer
• BAY 43-9006 (Sorafenib) to Treat Patients With Kaposi's Sarcoma
• Aranesp and Neulasta in Patients With Sarcoma Receiving Adriamycin and Ifosfamide
• Trial of Primary Prophylaxis With rhTPO Administered to Patients With High Risk Sarcoma Receiving Intensive Chemotherapy
• Irinotecan in Treating Patients With Newly Diagnosed Ewing's Sarcoma
• Safety Study of IPI-504 in Patients With Gastrointestinal Stromal Tumors (GIST) or Soft Tissue Sarcomas (STS)
• Phase IB Study of Gemcitabine, Docetaxel and Bevacizumab in Patients With Soft Tissue Sarcoma
• Evaluate PKs and Efficacy Assessment of Palifermin in Patients With Sarcoma
• Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Sarcoma
• Samarium Sm 153 and Stem Cell Transplant Followed By Radiation Therapy Patients With Osteosarcoma
• Sorafenib in Treating Patients With Advanced or Recurrent Uterine Cancer
• Nelfinavir Mesylate in Treating Patients With Recurrent, Metastatic, or Unresectable Liposarcoma
• Gemcitabine With or Without Docetaxel as Second-Line Therapy in Treating Patients With Metastatic or Relapsed, Unresectable Uterine or Soft Tissue Leiomyosarcoma
• S0505 Sorafenib in Treating Patients With Advanced Soft Tissue Sarcomas
• Paclitaxel in Treating Patients With Locally Advanced or Metastatic Soft Tissue Angiosarcoma or Lymphangiosarcoma That Cannot Be Removed By Surgery
• A Study to Provide Access to Trabectedin in Participants With Locally Advanced or Metastatic Soft Tissue Sarcoma Who Have Persistent or Recurrent Disease and Who Are Not Expected to Benefit From Currently Available Standard of Care Treatment
• Neoadjuvant Adriamycin and Ifosfamide Plus High-Dose ICE in Patients With Soft Tissue Sarcoma (STS)
• Bendamustin Hydrochloride in Patients With Soft Tissue Sarcoma (STS)
• Trofosfamide Versus Adriamycin in Elderly Patients With Soft Tissue Sarcoma (STS)
• Continuous Temozolomide in Patients With Advanced or Metastatic Soft Tissue Sarcoma or Metastatic Breast Cancer
• Evaluation of Side Effects and Relative Activity of Two Chemotherapy Regimens in the Treatment Soft Tissue Sarcoma
• Everolimus for Treating Pediatric Patients With Recurrent or Refractory Tumors
• Isolated Pelvic and Limb Perfusion in the Treatment of Locally Advanced Sarcoma of Pelvis and Limbs' Girdle
• Tandem Peripheral Blood Stem Cell (PBSC) Rescue for High Risk Solid Tumors
• Intensive Chemo-Radiotherapy With Peripheral Blood Progenitor Cell Rescue for Children With Advanced Neuroblastoma and Sarcomas
• The Addition of Polychemotherapy to Adjuvant Radiotherapy in the Treatment of Non-Metastatic Uterine Sarcomas
• Trial of Cetuximab in Patients With Metastatic and/or Locally Advanced Soft Tissue and Bony Sarcomas
• Comparison of Gemcitabine v. Gemcitabine Plus Docetaxel in Unresectable Soft Tissue Sarcoma
• A Study of Anti-CTLA4 Antibody in People With Advanced Synovial Sarcoma
• Study of Gemcitabine and Vinorelbine in Soft Tissue Sarcomas
• a Multicenter Clinical Trial for the Treatment of Children and Adolescents With Soft Tissue Sarcoma Stage 4
• PTK787/ZK222584 in the Treatment of Metastatic Gastrointestinal Stromal Tumors Resistant to Imatinib
• Study Comparing 12 Months Versus 36 Months of Imatinib in the Treatment of Gastrointestinal Stromal Tumor (GIST)
• Donor Stem Cell Transplant in Treating Young Patients With Relapsed or Refractory Solid Tumors
• Paclitaxel and Carboplatin in Treating Patients With Persistent or Recurrent Stage III or Stage IV Uterine Cancer
• Depsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue Sarcoma
• A Safety Study Utilizing Yondelis and Doxorubicin in Patients With a Type of Cancer Called Soft Tissue Sarcoma
• Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas
• Docetaxel, Gemcitabine, and Filgrastim (G-CSF) or Pegfilgrastim in Treating Patients With Advanced, Persistent, or Recurrent Uterine Leiomyosarcoma
• Doxorubicin Hydrochloride and Alvocidib in Treating Patients With Metastatic or Recurrent Sarcoma That Cannot Be Removed By Surgery
• Valganciclovir in Treating Patients With Classic Non-HIV-Associated Kaposi's Sarcoma
• Tanespimycin in Treating Young Patients With Recurrent or Refractory Leukemia or Solid Tumors
• Celecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced Cancer
• MRI Sarcoma Non Invasive Thermometry
• Study of AP23573/MK-8669 (Ridaforolimus), A Mammalian Target of Rapamycin (mTOR) Inhibitor, in Participants With Advanced Sarcoma (MK-8669-018 AM1)(COMPLETED)
• Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment
• Imatinib Mesylate in Treating Patients With HIV-Related Kaposi's Sarcoma
• Preoperative Thalidomide With Radiation Therapy For Patients With Low-Grade Primary Soft Tissue Sarcoma or Thalidomide With Radiation Therapy and Chemotherapy For Patients With High-Grade or Intermediate-Grade Primary Soft Tissue Sarcoma of the Arm,
• Radiolabeled MAB Therapy in Patients With Refractory, Recurrent, or Advanced CNS or Leptomeningeal Cancer
• A Study of STA-4783 in Combination With Weekly Paclitaxel for Treatment of Patients With Soft Tissue Sarcomas
• EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer
• CCI-779 in Treating Patients With Soft Tissue Sarcoma or Gastrointestinal Stromal Tumor
• Imatinib Mesylate in Treating Patients With Locally Advanced or Metastatic Dermatofibrosarcoma Protuberans or Giant Cell Fibroblastoma
• Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant Diseases
• Imatinib Mesylate in Treating Patients With Locally Recurrent or Metastatic Dermatofibrosarcoma Protuberans
• Efficacy and Safety Evaluation of Pegamotecan (PEG-camptothecin) in Advanced or Metastatic Soft Tissue Sarcoma
• Erlotinib and Temozolomide in Treating Young Patients With Recurrent or Refractory Solid Tumors
• Irinotecan and Carboplatin as Upfront Window Therapy in Treating Patients With Newly Diagnosed Intermediate-Risk or High-Risk Rhabdomyosarcoma
• Valproic Acid in Treating Patients With Kaposi's Sarcoma
• Gemcitabine and Docetaxel in Treating Patients With Recurrent Osteosarcoma (Closed to Accrual as of 12/21/06) or Ewing's Sarcoma or Unresectable or Locally Recurrent Chondrosarcoma
• Surgery and/or Chemotherapy in Treating Children With Infantile, Congenital, or Childhood Fibrosarcoma
• Trabectedin in Treating Young Patients With Recurrent or Refractory Soft Tissue Sarcoma or Ewing's Family of Tumors
• S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor
• Perifosine in Treating Patients With Advanced Soft Tissue Sarcoma
• Soblidotin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma
• Halofuginone Hydrobromide in Treating Patients With HIV-Related Kaposi's Sarcoma
• Alanosine in Treating Patients With Cancer
• Imatinib Mesylate in Treating Patients With Recurrent Ewing's Family of Tumors or Desmoplastic Small Round-Cell Tumor
• Doxorubicin With or Without Ifosfamide and Pegfilgrastim in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma
• Vinblastine, Celecoxib, and Combination Chemotherapy in Treating Patients With Newly-Diagnosed Metastatic Ewing's Sarcoma Family of Tumors
• Study Evaluating the Safety and Efficacy of ABT-510 in Subjects With Locally Advanced or Metastatic Soft Tissue Sarcoma
• Exatecan Mesylate in Treating Patients With Ewing's Sarcoma, Primitive Neuroectodermal Tumor, or Desmoplastic Small Round Cell Tumor
• Perifosine in Treating Patients With Metastatic or Locally Advanced Soft Tissue Sarcoma
• Gefitinib in Treating Patients With Locally Advanced or Metastatic Synovial Sarcoma
• Doxorubicin and Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Soft Tissue Sarcoma
• Stem Cell Transplantation in Patients With High-Risk and Recurrent Pediatric Sarcomas
• Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver
• Brostallicin in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma
• Exatecan Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma
• Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia
• Liposomal Vincristine for Pediatric and Adolescent Patients With Relapsed Malignancies
• Vincristine, Doxorubicin, Cyclophosphamide and Dexrazoxane (VACdxr) in High Risk Ewing's Sarcoma Patients
• ABT-751 in Treating Young Patients With Refractory Solid Tumors
• Pegfilgrastim as Support to Pediatric Sarcoma Patients Receiving Chemotherapy
• Temozolomide and Thalidomide in Treating Patients With Metastatic, Locally Advanced, or Unresectable Leiomyosarcoma
• Combination Chemotherapy Plus Sargramostim in Treating Patients With Cancer of the Uterus
• Liposomal Doxorubicin and Carboplatin in Treating Patients With Gynecologic Cancer
• Imatinib Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma or Bone Sarcoma
• Liposomal Doxorubicin Plus Ifosfamide in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma
• Imatinib Mesylate in Treating Patients With Relapsed or Refractory Solid Tumors of Childhood
• Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven't Responded to Therapy
• Photodynamic Therapy System for Patients With Refractory/Unresponsive Solid Tumors
• Bortezomib in Treating Patients With Advanced or Metastatic Sarcoma
• Interferon Alfa and Thalidomide in Treating Patients With Soft Tissue Sarcoma or Bone Sarcoma
• Combination Chemotherapy in Treating Children With Metastatic Rhabdomyosarcoma or Other Malignant Mesenchymal Tumors
• Chemotherapy Followed by Surgery and Radiation Therapy With or Without Stem Cell Transplant in Treating Patients With Relapsed or Refractory Wilms' Tumor or Clear Cell Sarcoma of the Kidney
• Arsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid Tumors
• BMS-275291 in Treating Patients With HIV-Related Kaposi's Sarcoma
• Photodynamic Therapy in Treating Patients With Skin Cancer or Solid Tumors Metastatic to the Skin
• Chemotherapy, SU5416, Radiation Therapy, and Surgery in Treating Patients With Soft Tissue Sarcoma
• Radiation Therapy With or Without SU5416 in Treating Patients With Soft Tissue Sarcoma
• BMS-247550 in Treating Patients With Advanced Soft Tissue Sarcoma
• A Phase II Trial of COL-3 in Patients With HIV Related Kaposi's Sarcoma
• Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma
• Liposomal Doxorubicin and Interleukin-12 in Treating Patients With AIDS-Related Kaposi's Sarcoma
• Vaccine Therapy in Treating Patients With Metastatic Cancer
• Temozolomide and O6-benzylguanine in Treating Children With Solid Tumors
• Isolated Limb Perfusion of Melphalan With or Without Tumor Necrosis Factor in Treating Patients With Soft Tissue Sarcoma of the Arm or Leg
• Liposomal Doxorubicin in Treating Children With Refractory Solid Tumors
• Antiviral Therapy in Treating Patients With Kaposi's Sarcoma With or Without HIV Infection
• Interleukin-12 in Treating Patients With AIDS-Related Kaposi's Sarcoma
• Thalidomide in Treating Patients With HIV-Associated Kaposi's Sarcoma
• CP4071 in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma
• Combination Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Primary or Recurrent Sarcoma
• Ecteinascidin 743 in Treating Patients With Unresectable Advanced or Metastatic Soft Tissue Sarcoma
• Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors
• Chemotherapy in Treating Patients With Metastatic Ewing's Sarcoma or Primitive Neuroectodermal Tumor
• Flavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or Lymphomas
• Peripheral Stem Cell Transplantation Plus Chemotherapy in Treating Patients With Malignant Solid Tumors
• Comparison of Combination Chemotherapy Regimens in Treating Patients With Ewing's Sarcoma or Neuroectodermal Tumor
• STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma
• EMD 121974 in Treating Patients With HIV-Related Kaposi's Sarcoma
• Thalidomide in Treating Patients With Gynecologic Sarcomas
• Flavopiridol in Treating Patients With Recurrent, Locally Advanced, or Metastatic Soft Tissue Sarcoma
• Temozolomide Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Malignant Glioma or Recurrent CNS or Other Solid Tumors
• SU5416 in Patients With AIDS-Related Kaposi's Sarcoma Who Have Not Responded to Treatment
• Nitrocamptothecin in Treating Patients With Soft Tissue Sarcomas
• SU5416 in Treating Patients With Advanced, Metastatic, or Recurrent Soft Tissue Sarcomas
• Chemotherapy in Treating Patients With Sarcoma of the Uterus
• O6-benzylguanine and Carmustine in Treating Patients With Recurrent, Metastatic, or Locally Advanced Soft Tissue Sarcoma
• SU5416 in Treating Patients With AIDS-Related Kaposi's Sarcoma
• EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma
• Isolated Limb Infusion of Chemotherapy in Treating Patients With Melanoma or Soft Tissue Sarcoma of the Arm or Leg That Cannot Be Removed By Surgery
• 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or Sarcoma
• Rosiglitazone in Treating Patients With Liposarcoma
• Radiation Therapy Plus Doxorubicin in Treating Patients With Resectable Primary or Recurrent Retroperitoneal Soft Tissue Sarcoma
• Doxorubicin Plus External-Beam Radiation Therapy in Treating Patients With Soft Tissue Sarcoma
• Gemcitabine, Docetaxel, and Filgrastim in Treating Patients With Recurrent or Persistent Leiomyosarcoma or Soft Tissue Sarcoma
• Combination Chemotherapy in Treating Patients With Previously Untreated Rhabdomyosarcoma
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Metastatic Rhabdomyosarcoma or Sarcoma
• Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma
• Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors
• Dolastatin 10 in Treating Patients With Recurrent or Metastatic Soft Tissue Sarcoma
• Chemotherapy in Treating Children With Recurrent or Refractory Sarcomas
• SU5416 in Treating Patients With AIDS-Related Kaposi's Sarcoma
• Irinotecan in Treating Patients With Stage IV or Recurrent Soft Tissue Sarcoma
• Temozolomide in Treating Patients With Advanced Soft Tissue Sarcoma
• Combination Chemotherapy and Biological Therapy in Treating Patients With High-Risk Ewing's Sarcoma
• High-dose ICE With Amifostine
• Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial Cancer
• Antineoplaston Therapy in Treating Patients With Soft Tissue Sarcoma
• Antineoplaston Therapy in Treating Patients With Metastatic, Recurrent, or Refractory Primitive Neuroectodermal Tumors
• Phase I/II Study of Escalating-Dose Melphalan w/Autologous SCS & Amifostine Cytoprotect
• Paclitaxel Compared With Doxorubicin in Treating Patients With Advanced AIDS-Related Kaposi's Sarcoma
• Combination Chemotherapy in Treating Patients With Endometrial Cancer, Fallopian Tube Cancer, or Sarcoma of the Female Reproductive Tract
• Gemcitabine in Treating Patients With Recurrent or Refractory Cancer of the Uterus
• Vinorelbine in Treating Children With Recurrent or Refractory Cancers
• Ifosfamide or Doxorubicin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma
• Liposomal Doxorubicin and PSC 833 in Treating Patients With AIDS-Related Kaposi's Sarcoma or Other Advanced Cancers
• Topotecan in Treating Patients With Recurrent or Refractory Cancer of the Uterus
• Ifosfamide With or Without Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cancer of the Uterus
• Combination Chemotherapy, Peripheral Stem Cell Transplantation, and Radiation Therapy in Treating Patients With Ewing's Sarcoma, Peripheral Primitive Neuroectodermal Tumor, or Rhabdomyosarcoma
• Troglitazone in Treating Patients With Liposarcoma
• Paclitaxel in Treating Patients With Recurrent or Persistent Cancer of the Uterus
• Combination Chemotherapy With or Without Hyperthermia Therapy in Treating Patients With Soft Tissue Sarcoma
• Paclitaxel in Treating Patients With AIDS-Related Kaposi's Sarcoma
• Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma
• Combination Chemotherapy in Treating Patients With Recurrent or Advanced Cancer of the Uterus
• Doxorubicin in Treating Patients With AIDS-Related Kaposi's Sarcoma
• Whole-Body Hyperthermia Plus Chemotherapy in Treating Patients With Advanced Sarcoma
• Altretamine and Etoposide in Treating Patients With HIV-Related Cancer
• Surgery Followed by Chemotherapy in Treating Young Patients With Soft Tissue Sarcoma
• Cryosurgery in Treating Patients With Soft Tissue Sarcoma
• Docetaxel in Treating Children With Recurrent Solid Tumors
• Combination Chemotherapy, Surgery, and Radiation Therapy in Treating Children With Advanced Soft Tissue Sarcoma
• Chemotherapy Plus Radiation Therapy Followed by Surgery in Treating Patients With Soft Tissue Sarcoma
• Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma
• Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Ewing's Sarcoma or Primitive Neuroectodermal Tumor
• Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma
• Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors
• Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Sarcoma
• Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Cancer of the Uterus
• Chemotherapy in Treating Patients With Advanced Sarcoma
• Combination Chemotherapy Plus Surgery and Radiation Therapy in Treating Patients With Ewing's Sarcoma
• Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancer
• Combination Chemotherapy in Treating Patients With Soft Tissue Sarcoma
• Combination Chemotherapy and Radiation Therapy in Treating Patients With Peripheral Neuroectodermal Tumors, Ewing's Sarcoma, Wilms' Tumor, or Bone Cancer
• Safety and Effectiveness of an Experimental Drug, IM862, in Treating Kaposi's Sarcoma in AIDS Patients
• A Study of ALRT 1057 Topical Gel in Patients With AIDS-Related Kaposi's Sarcoma
• The Safety and Effectiveness of Ritonavir in the Treatment of HIV-Related Kaposi's Sarcoma
• A Study of Tecogalan Sodium
• A Study of DOX-SL in the Treatment of AIDS-Related Kaposi's Sarcoma
• A Comparison of DOX-SL Versus Adriamycin Plus Bleomycin Plus Vincristine in the Treatment of Severe AIDS-Related Kaposi's Sarcoma
• A Study of Ro 24-7429 in Patients With HIV-Related Kaposi's Sarcoma
• A Phase I/II Study of Intralesional Recombinant Tumor Necrosis Factor in Patients With AIDS-Related Cutaneous Kaposi's Sarcoma
• Phase II Study of Intravenous Novantrone(R) in the Treatment of AIDS Related Kaposi's Sarcoma
• Safety and Effectiveness of Giving SU5416 to HIV-Infected Patients With AIDS-Related Kaposi's Sarcoma
• A Study of Targretin Capsules in Patients With AIDS-Related Kaposi's Sarcoma
• Paclitaxel in Advanced Refractory Kaposi's Sarcoma (AIDS-KS): A Phase II Trial of Paclitaxel From Baker Norton Pharmaceuticals
• A Study of ALRT1057 in Patients With AIDS-Related Kaposi's Sarcoma
• A Pilot, Open-Label, Phase II, Randomized Study to Determine the Effects of Viracept on the Outcome of Cutaneous and Mucosal KS in AIDS Patients With CD4 <= 500 Cells/mm3
• Photodynamic Therapy Clinical Trial For Cutaneous AIDS-Related Kaposi's Sarcoma Study Summary.
• Topical Use of 4,4'-Dihydroxybenzophenone-2,4-Dinitrophenylhydrazone (A-007) in the Treatment of Advanced Malignancies Including Kaposi's Sarcoma and Lymphoproliferative Disorders
• Use of Stealth Liposomal Doxorubicin HCl ( DOX-SL ) in the Treatment of Moderate to Severe AIDS-Related Kaposi's Sarcoma.
• A Phase I Trial of Tecogalan Sodium ( DS-4152 ) Administered as an Infusion Twice Weekly for 21 Days.
• A Phase I Trial of Tecogalan Sodium ( DS-4152 ) Administered as an Infusion Weekly x 4
• A Phase I Trial of Tecogalan Sodium (DS-4152) Administered as an Infusion Every 21 Days
• A Pilot Study of OPC-8212 (Vesnarinone) in Persons With AIDS-Related Kaposi's Sarcoma
• Randomized, Comparative Trial of DOX-SL (Stealth Liposomal Doxorubicin Hydrochloride) Versus Bleomycin and Vincristine in the Treatment of AIDS-Related Kaposi's Sarcoma
• A Randomized Phase III Clinical Trial of Daunoxome Versus Combination Chemotherapy With Adriamycin/Bleomycin/Vincristine (ABV) in the Treatment of HIV-Associated Kaposi's Sarcoma.
• A Phase I Study of SU101 in Pediatric Patients With Refractory Malignancy
• A Pilot Study of Autologous T-Cell Transplantation With Vaccine Driven Expansion of Anti-Tumor Effectors After Cytoreductive Therapy in Metastatic Pediatric Sarcomas
• A Pilot Study of Tumor-Specific Peptide Vaccination and IL-2 With or Without Autologous T Cell Transplantation in Recurrent Pediatric Sarcomas
• Twins Study of Gene Therapy for HIV Infection
• New Therapeutic Strategies for Patients With Ewing's Sarcoma Family of Tumors, High Risk Rhabdomyosarcoma, and Neuroblastoma
• A Randomized Study of the Effect of Adjuvant Chemotherapy With Doxorubicin and Ifosfamide With Mesna in the Treatment of High-Grade Adult Extremity Soft Tissue Sarcoma
• A Pilot Study for the Treatment of Patients With Metastatic and High Risk Sarcomas and Primitive Neuroectodermal Tumors
• The Safety and Effectiveness of Interferon Alfa-2B Plus Didanosine in Patients With Kaposi's Sarcoma
• A Study of AZT Plus Human Interferon Alpha in the Treatment of AIDS-Related Kaposi's Sarcoma
• Comparison of Liposomal Doxorubicin Used Alone or in Combination With Bleomycin Plus Vincristine in the Treatment of Kaposi's Sarcoma in Patients With AIDS
• A Study of Doxorubicin in the Treatment of AIDS-Related Kaposi's Sarcoma
• A Study of AZT in HIV-Infected Patients With AIDS-Related Kaposi's Sarcoma
• A Study of Chemotherapy Plus Azidothymidine in the Treatment of Kaposi's Sarcoma in Patients With AIDS
• A Study of Chemotherapy Plus ddI or ddC in the Treatment of AIDS-Related Kaposi's Sarcoma
• Phase II Evaluation of Low-Dose Oral Etoposide for the Treatment of Relapsed or Progressed AIDS-Related Kaposi's Sarcoma After Systemic Chemotherapy
• A Phase I/II Study of Recombinant Interleukin-4 in AIDS and Kaposi's Sarcoma
• A Phase I Study of TNP-470 in the Treatment of AIDS-Associated Kaposi's Sarcoma
• A Phase I Study of AZT and Human Interferon Alpha (Recombinant Alpha-2A and Lymphoblastoid) in the Treatment of AIDS-Associated Kaposi's Sarcoma
• Open Label Phase I Study To Evaluate the Safety of Combination Therapy With AZT and Interferon-Beta in Patients With AIDS Related Kaposi's Sarcoma
• A Phase I Trial of Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor (rHuGM-CSF), Recombinant Alpha Interferon and Azidothymidine (AZT) in AIDS-Associated Kaposi's Sarcoma
• Phase II Study of Zidovudine and Recombinant Alpha-2A Interferon in the Treatment of Patients With AIDS-Associated Kaposi's Sarcoma
• A Phase I Study of the Combination of Recombinant GM-CSF, AZT, and Chemotherapy (ABV) (Adriamycin, Bleomycin, Vincristine) in AIDS and Kaposi's Sarcoma
• Phase I Study of Weekly Oral VP-16 for AIDS-Associated Kaposi's Sarcoma